The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas-kidney recipients with previous transplants

Clinical Transplantation

Volumn 15, Issue 2, 2001, Pages 142-145

  Ciancio, Gaetano ^a   Miller, Joshua ^a   Burke, George W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Induction therapy; Mycophenolate mofetil; Previous transplants; Simultaneous pancreas kidney transplants; Tacrolimus

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; AZATHIOPRINE; C PEPTIDE; CALCINEURIN INHIBITOR; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; STEROID; TACROLIMUS;

ADULT; ARTICLE; CADAVER DONOR; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPPORTUNISTIC INFECTION; PANCREAS FUNCTION; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; STEROID THERAPY; THROMBOSIS;

ADULT; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; REOPERATION; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 0035098554     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150211.x     Document Type: Article

References (27)

1. Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage
2. The analysis of benefit and risk of combined pancreatic and renal transplantation versus renal transplantation alone
3. Combined kidney/pancreas transplantation in diabetes mellitus
4. Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS)
5. A multi-center analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation
6. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine
7. Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506
8. Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation
9. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60
10. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction
11. - thymocytes subset by FK506 analogs correlates with their immunosuppressive and calceneurin activities
12. A randomized prospective comparison of MALG with OKT3 for rescue therapy of acute myocardial rejection
13. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation
14. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation
15. Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis
16. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era
17. Analysis of infections complications occurring after solid-organ transplantation
18. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients
19. Post-transplant lymphoproliferative disorder in renal allograft recipients: Clinical experience and risk factor analysis in a single center
20. Successful retreatment with OKT3
21. Effectiveness of a second course of OKT3 monoclonal anti-T.-cell antibody for treatment of renal allograft rejection
22. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation
23. Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: Results of a prospective randomized single-center study
24. First results with quadruple therapy including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation
25. Pancreas transplantation without antibody therapy
26. Simultaneous kidney-pancreas transplantation without antilymphocyte induction
27. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings